Johnson & Johnson recently announced that the CDC’s Advisory Committee on Immunization Practices (ACIP) recommended its single-shot COVID-19 vaccine under the recent FDA emergency use...
GSK recently announced results from a Phase 2 proof-of-concept trial evaluating its investigational monoclonal antibody treatment, otilimab.
The OSCAR study evaluated the efficacy and safety of...
Moderna recently announced that it has shipped doses of its variant-specific COVID-19 vaccine candidate to the National Institutes of Health (NIH) for a Phase 1 clinical trial.
NIAID will conduct the...
Pfizer and BioNTech recently announced the submission of new data to FDA demonstrating the stability of their COVID-19 vaccine when stored at higher temperatures.
Specifically, the...
Moderna recently announced that it is making new capital investments to increase global manufacturing capacity of its COVID-19 vaccine, mRNA-1273.
The company will make investments to increase...
Pfizer and BioNTech recently announced that the first participants have been dosed in a global Phase 2/3 study to further evaluate their COVID-19 vaccine in healthy pregnant women.
The randomized,...
FDA recently issued three guidance documents for COVID-19 vaccine developers and other medical product creators covering to address the current and potential future emergence of variants of...
FDA has issued an emergency use authorization for a third COVID-19 vaccine to Johnson & Johnson, which will be distributed in the US for use in individuals 18 years of age and older.
The...
Promise of the world returning to normal hinges on COVID-19 vaccine rollout. Talk of herd immunity has given people hope that large gatherings, indoor dining, and sporting events will once again become a part of everyday life, or at least...
A recent FDA analysis found that Johnson & Johnson’s COVID-19 vaccine met requirements for emergency use authorization.
The data submitted to FDA by the pharmaceutical company was from...
HHS recently announced new actions to expand COVID-19 testing capacity across the US as part of President Joe Biden’s National Strategy for the COVID-19 Response and Pandemic Preparedness.
The...
The World Health Organization (WHO) recently granted AstraZeneca’s COVID-19 vaccine emergency use listing (EUL) for active immunization to prevent coronavirus in individuals 18 years of age and...
AstraZeneca and IDT Biologika recently partnered to boost manufacturing and supply capacity for COVID-19 Vaccine AstraZeneca in the second quarter of 2021.
The companies will also launch a joint...
Eli Lilly and Company recently partnered with local health systems to enhance access to crucial COVID-19 antibody therapies.
The partnership will work to launch dedicated infusion center...
CVS Health recently announced that it is expanding access to COVID-19 vaccines to eligible populations at a limited number of CVS Pharmacy locations across 11 states.
In total, there will be...
Siemens Healthineers recently announced that it received the CE mark to use anterior nose swab sampling for its COVID-19 antigen test.
The CLINITEST Rapid COVID-19 Antigen Test is a point-of-care...
FDA recently issued an emergency use authorization to Eli Lilly & Company for its combination COVID-19 antibody treatment.
The authorization states that providers can administer the...
Roche recently announced that it received the CE mark for its new self-administered COVID-19 antigen test, which will be available in countries accepting the CE mark by the middle of this...
GSK and CureVac recently announced a $180.5 million collaboration to jointly develop next-generation mRNA COVID-19 vaccines.
The companies will contribute resources and expertise to research, develop,...
HHS recently issued a fifth amendment to the Declaration under the Public Readiness and Emergency Preparedness Act (PREP Act) to add categories of qualified persons authorized to prescribe,...
